疏肝扶正抗喻方联台调强放疗治疗老年食管嘘临床观察  

作　　者：周东亚 华明军[1] 王小龙[1] 周雷[1] 孙波[1] 李智强[1] 徐彬[1] 徐增柏 

机构地区：[1]沭阳县中医院,江苏沭阳223600

出　　处：《中文科技期刊数据库（引文版）医药卫生》2015年第3期7-8,共2页

摘　　要：观察疏肝扶正抗癌方联合调强放疗治疗老年食管癌临床疗效。方法:36倒老年食管癌患者随机分成2纽,每组18例,治疗组行放疗+疏肝扶正抗癌方应用,对照组予单纯放疗。2组均采用6MV射线调强放射治疗,食管癌原发灶剂量64—66Gy。结果:治疗组和对照组的有效率(CR+PR)分别为77.8%和55.6%,组问比较有显著性差异。生活质量评分比较治疗组高于对照组,有统计学意义。毒副反应对照组高于治疗组。主要表现为放射性损伤。结论:疏肝扶正抗癌方联合放疗治疗老年食管癌有效、安全,毒副反应轻。Objective:To observe the liver righting can.cer Co - IMRT elderly esophageal cancer clinical efficacy. Methods:36 cases of elderly pa- tients with esophageal cancer were randomly divided into two groups of 18 patients in each treatment group fighting cancer radiotherapy + Shugan party applications, control group received radiotherapy alone. 2 groups were 6MV ray intensity modulated radiation therapy, esophageal primary tumor dose 64 66 Gy. Results:The treatment group and control group response rate (CR + PR)was 77. 8 % and 55.6%, there was a significant difference between the two groups. Quality of life score was higher in the treatment group was statistically significant. Toxicity control group was higher than the treatment group, mainly for radiation injury. Conclusion:Liver righting cancer radiotherapy in elderly esophageal party effective, safe, light toxicity.

关 键 词：疏肝扶正抗癌方 调强放疗 

分 类 号：R19[医药卫生—卫生事业管理]